BIOREM Inc.
BIRMF
$2.58
$0.083.23%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.15M | 8.17M | 6.82M | 3.30M | 6.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.15M | 8.17M | 6.82M | 3.30M | 6.65M |
| Cost of Revenue | 7.89M | 5.87M | 4.97M | 2.52M | 5.51M |
| Gross Profit | 4.26M | 2.30M | 1.84M | 773.30K | 1.14M |
| SG&A Expenses | 1.52M | 1.10M | 1.07M | 712.70K | 925.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 0.00 | -- | -- | -81.90K |
| Total Operating Expenses | 9.39M | 7.01M | 6.05M | 3.25M | 6.36M |
| Operating Income | 2.76M | 1.16M | 764.50K | 50.90K | 292.60K |
| Income Before Tax | 2.65M | 1.14M | 732.40K | 35.20K | 171.20K |
| Income Tax Expenses | 582.90K | 303.00K | 194.10K | 9.30K | 49.20K |
| Earnings from Continuing Operations | 2.06M | 840.40K | 538.30K | 25.90K | 122.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.06M | 840.40K | 538.30K | 25.90K | 122.00K |
| EBIT | 2.76M | 1.16M | 764.50K | 50.90K | 292.60K |
| EBITDA | 2.82M | 1.25M | 843.50K | 144.60K | 342.80K |
| EPS Basic | 0.14 | 0.05 | 0.03 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.11 | 0.04 | 0.03 | 0.00 | 0.01 |
| EPS Diluted | 0.12 | 0.05 | 0.03 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.10 | 0.04 | 0.02 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 14.87M | 16.01M | 16.03M | 18.58M | 15.66M |
| Average Diluted Shares Outstanding | 16.73M | 18.63M | 18.61M | 18.58M | 18.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |